Navigation Links
Norfolk PCTs To Offer Herceptin

There's joy and relief at Norfolk as surgeons at the Norfolk and Norwich University Hospital have been given the green signal to make available the breast// cancer drug Herceptin to women who test positive for her-2 gene.

"We made the business case and submitted it to the therapeutic advisory groups, and the primary care trusts have backed the package," confirmed Simon Pain, consultant breast surgeon at the N&N. "About one in five women with breast cancer will be sensitive to Herceptin. We will test every breast cancer patient for it and if they are sensitive to it and it needs prescribing, then we will prescribe it." Some guidelines have been put into place for the women to be eligible to take the drug. Firstly a woman must test positive for the HER-2 receptor. But since only 20 percent carry this receptors, it is felt that this decision will only benefit a minority. "I think the results from Herceptin are probably the most significant and impressive from any single drug for breast cancer. And I think for those one in five women this is a great leap forward and those tested will be offered the drug if deemed appropriate," Pain said. "We have already been using Herceptin for some time for patients with advanced disease but the evidence shows it can be of use in early stages post-op." As of now, Herceptin is still not licensed for use in early stages of breast cancer and NICE (National Institute of Health and Clinical Excellence) is yet to clarify the matter.
'"/>




Page: 1

Related medicine news :

1. Culling Complete at Norfolk farms
2. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
3. Drug Offers Hope for Alzheimers disease
4. Drug Firm Offers to Donate Smallpox Vaccine
5. Stem Cells Found To Offer Promise For Hair Growth
6. fMRI Offers Insight Into An Infants Brain
7. Diet Found To Offer Protection Against Leukemia
8. Gel Offers A More Targeted Approach
9. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
10. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
11. A New Product Offering protection against anthrax
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... Diego, CA (PRWEB) , ... May 05, 2016 , ... ... dashboard and dedicated Twitter feed to cover the latest news and commentary at the ... through 10th. This meeting of the American Society of Cataract and Refractive Surgery and ...
(Date:5/5/2016)... Lawrence, Kansas (PRWEB) , ... May 05, 2016 ... ... well-known that some macroalgae can use ultraviolet light A (UV-A) for photosynthesis, researchers ... range of red, green, and brown seaweeds. The pair observed that when photosynthetically ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... and Make-A-Wish grants the most heartfelt wishes of these children. The wishes ... medical treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In ...
(Date:5/5/2016)... ... 2016 , ... Long Island’s fastest growing comprehensive eye care provider, North ... Kathleen Van Valkenburg, MD as part of their ongoing effort to increase ophthalmic coverage ... managing partner of North Shore Eye Care. , “We are extremely proud to ...
(Date:5/5/2016)... ... , ... TIME for Kids and The ZAC Foundation – a national leader ... nearly 1 million children with important water safety messages before summer break begins. ... accidental death in children one to 6 years of age. TIME for Kids ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... Research and Markets has announced the addition ... Outlook 2020" report to their offering. ... has improved significantly in past years due to which ... years. Many cancer drugs have been developed by utilization ... expected to be developed with its help. They are ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
Breaking Medicine Technology: